Synthetic Biologics’ sniper approach to infectious diseases
Taking a page out of the oncology sector and its approach to targeting specific cancers with new biologics, Synthetic Biologics (NYSE MKT:SYN) is developing treatments for infectious diseases in much...
View ArticleStellar Biotechnologies harvests mollusks for KLH protein
A mollusk living in the coastal waters off California from Monterey to the Baja Peninsula may hold the key to new therapies to treat cancer and autoimmune diseases. Frank Oakes Stellar Biotechnologies...
View Article
More Pages to Explore .....